Glembatumumab vedotin
Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate with potent anticancer effects, utilized in the study of triple negative breast cancer (TNBC) .
Product Specifications
CAS Number
1182215-65-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximatel 149.16 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Microtubule Associated | Antibody-Drug Conjugates (ADCs)
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
